Disease index

inborn errors of protein metabolism

Metabolic · 2014–2024

6decisions
6medicines
0carried consumer input
0individual submissions

No submission for this condition has carried consumer input, including the 6 made since the comments facility came into use.

Every decision

MedicineMeetingOutcomeConsumer input
triglycerides, long chain with glucose polymer Treatment of proven inborn errors of protein metabolism in patients unable to meet their energy requirements with permitted food and formulae. Nov 2024 Recommended with restriction none received
amino acid formula with vitamins and minerals (multiple formulations) Nutritional management of patients with inborn errors of protein metabolism (homocystinuria, phenylketonuria, tyrosinaemia, and maple syrup urine disease) from… Jul 2021 Recommended with restriction unclear
carbohydrate, fat, vitamins, minerals and trace elements formula Proven inborn errors of protein metabolism. Jul 2020 Recommended none received
triglycerides medium chain and long chain with glucose polymer Dietary management of proven inborn errors of protein metabolism. Mar 2020 Recommended with restriction none received
carbohydrate formula with minerals Nutritional supplementation for proven inborn errors of protein metabolism and proven inborn errors of fat metabolism. Nov 2016 Not recommended none received
triglycerides long chain with glucose polymer Inborn errors of protein metabolism (IEM) in patients unable to meet their energy requirements with permitted food and formulae. Jul 2014 Recommended with restriction no section in document

What the PBS pays

$42M in government benefit over 2024–25, across 45,900 services.

This is spend on the medicines considered for this condition, not spend on the disease. A medicine used for several conditions is counted in full under each, so figures across conditions add to more than national PBS expenditure.

MedicineGovernment benefit
carbohydrate, fat, vitamins, minerals and trace elements $17.9M
amino acid formula with vitamins and minerals (multiple formulations) $17M
carbohydrate formula with minerals $6.7M
triglycerides long chain with glucose polymer $0.3M
triglycerides medium chain and long chain with glucose polymer $0.3M
triglycerides, long chain with glucose polymer $0.3M

Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 6 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.